Company Profile

ANUH PHARMA LTD.

NSE : NABSE : 506260ISIN CODE : INE489G01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE105.65-1.75 (-1.63 % )
PREV CLOSE (Rs.) 107.40
OPEN PRICE (Rs.) 109.85
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 23677
TODAY'S LOW / HIGH (Rs.)104.40 109.85
52 WK LOW / HIGH (Rs.) 90 172.8
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 1.42
TTM EPS (Rs.) 3.45
P/E Ratio 30.59
Book Value (Rs.) 39.16
Face Value (Rs.) 5
MCap (Rs. in Mn) 5294.33
Price/Earning (TTM) 16.73
Price/Sales (TTM) 1.25
Price/Book (MRQ) 2.70
PAT Margin (%) 6.46
ROCE (%) 19.75
Incorporation Year : 1960

Management Info :

Jasvantlal G Shah - Chairman - Managing Director

Registered Office :

Address : 3 - A, Shivsasgar Estate, North Wing,Dr. Annie Basant Road,Worli,
Mumbai,
Maharashtra-400018

Phone : 022-66227575

Email : anuh@sk1932.com

Website : www.anuhpharma.com

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
08Oct10-08-2021$Anuh Pharma informs about certificate Anuh Pharma informs about ce

Pursuant to the provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants), Regulations, 2018, Anuh Pharma has informed that it attached the copy of the certificate issued by Bigshare Services, the Registrar and Share Transfer Agent of the Company for the quarter ended 30th September, 2021.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the provisions of Regulation 74(5) of the Securitie..
24Sep09-24-2021$Anuh Pharma informs about closure of trading window Anuh Pharma informs about cl

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading)Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider Trading, Anuh Pharma has informed that the Trading window for dealing in the securities of the Company will be closed for the Designated Persons and their immediate relatives, from Thursday, September 30, 2021 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter & half year ended September 30, 2021.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the Securities and Exchange Board of India (Prohibi..
09Aug08-09-2021$ Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Disclosure Under Regulation
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that M/s SBU & Co., Chartered Accountants, (Firm Registration No. 147522W), has been appointed as Internal Auditors of the Company w.e.f. 1st July, 2021 to 31st March, 2022.
Pursuant to the provisions of Regulation 30 read with Schedule..
26Jul07-26-2021$ Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Board Meeting Intimation fo
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 6th August, 2021, inter alia: 1)To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June, 2021; and 2)To consider any other matter with the permission of the Chairman. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Wednesday, 30th June, 2021 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2021 i.e. upto Sunday, 8th August, 2021 (both days inclusive).
ANUH PHARMA LTD.has informed BSE that the meeting of the Board..
15Jul07-15-2021$Anuh Pharma informs about issuance of duplicate share certificate Anuh Pharma informs about is

Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 2015, Anuh Pharma has informed that the Company has issued duplicate share certificates, on receipt of proper documentation from the shareholder: Arvind Amratlal Patel (Folio No: 0000085), as confirmed by Bigshare Services Registrar and Share Transfer Agent of the Company, as per further details are attached.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 20..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit55.9100000000002284.37
Gross Profit 71.1500000000002 385.52
Operating Profit 102.82551.22
Net Sales 1172.724319.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Torrent Pharma (BSE)
 3084.55 (3.91%)
M.Cap ( in Cr)
52193.28
NGL Fine-Chem (BSE)
 2554.25 (4.38%)
M.Cap ( in Cr)
1578.02
Venus Remedies (BSE)
 502.90 (14.73%)
M.Cap ( in Cr)
672.23
Kwality Pharma (BSE)
 913.50 (5.00%)
M.Cap ( in Cr)
947.87
Dr. Reddy's Lab (BSE)
 4675.45 (0.85%)
M.Cap ( in Cr)
77798.93
Shareholding Pattern More
PROMOTERS 70.43 %
NON-INSTITUTION 29.57 %
FI/BANKS/INSURANCE 0 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
Nippon India Pharma Fun...2.44
F & O Quotes